Reduction of subjective distress in CBT for childhood OCD: nature of change, predictors, and relation to treatment outcome.
Katharina Kircanski, Monica Wu, John Piacentini
https://pubmed.ncbi.nlm.nih.gov/23774008Completed
Led by National Institute of Mental Health (NIMH) · Updated on 2008-02-12
N/A
Participants Needed
1
Research Sites
N/A
Total Duration
The purpose of this study is to evaluate a behavioral treatment program for children and adolescents with OCD and their families. Exposure and Response Prevention (ERP) behavior therapy, in which the patient is gradually exposed to the object or situation that causes anxiety and is taught to refrain from responding in a compulsive manner, is combined with family counseling (Family Treatment Program). This treatment will be compared to Relaxation Training (RT). OCD is a long-term, often disabling disorder that can cause significant family disruption. ERP is a promising treatment for children with OCD, and it is thought that family participation (through the Family Treatment Program) may be a helpful addition. RT is a common treatment for anxiety. Patients are assigned randomly (like tossing a coin) to receive either the ERP/Family Treatment Program or RT. Both treatments will be delivered over 12 90-minute outpatient sessions to youngsters and their families. All participants (patients and family members) will be assessed for treatment response each month during treatment, after treatment is finished, and then at 2 follow-up visits over the following 6 months. A child/adolescent may be eligible for this study if he/she: Has obsessive-compulsive disorder (OCD), is medication-free, and is 8 to 17 years old.
CONDITIONS
Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD)
You may qualify if you...
Inclusion Criteria:
-
Patients must have:
Obsessive-compulsive disorder for which he/she has not received medication.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Total: 1 location
1
Univ. of California / Los Angeles / Neuropsychiatric Inst.
Los Angeles, California, United States, 90024-1759
Status Unknown
Study Type
INTERVENTIONAL
Masking
N/A
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Katharina Kircanski, Monica Wu, John Piacentini
https://pubmed.ncbi.nlm.nih.gov/23774008John Piacentini, R Lindsey Bergman, Susanna Chang...
https://pubmed.ncbi.nlm.nih.gov/22024003